Iterum Therapeutics plc financial data

Symbol
ITRM on Nasdaq
Location
3 Dublin Landings, North Wall Quay, Dublin 1, Ireland
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 120 % -46.5%
Debt-to-equity -471 % +93.2%
Return On Equity 311 % -95.7%
Return On Assets -83.8 % +19.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40M shares +142%
Common Stock, Value, Issued 357K USD +116%
Weighted Average Number of Shares Outstanding, Basic 34.1M shares +121%
Weighted Average Number of Shares Outstanding, Diluted 34.1M shares +121%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.07M USD -81.2%
General and Administrative Expense 8.58M USD +13.4%
Operating Income (Loss) -16.2M USD +64%
Nonoperating Income (Expense) -6.07M USD -160%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -22.3M USD +36.3%
Income Tax Expense (Benefit) 252K USD -53.2%
Net Income (Loss) Attributable to Parent -22.6M USD +36.6%
Earnings Per Share, Basic -1 USD/shares +64.4%
Earnings Per Share, Diluted -1 USD/shares +64.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.7M USD +71.2%
Inventory, Net 533K USD
Assets, Current 13.5M USD -29.1%
Property, Plant and Equipment, Net 18K USD -59.1%
Operating Lease, Right-of-Use Asset 19K USD -95.9%
Intangible Assets, Net (Excluding Goodwill) 19.4M USD
Assets 33M USD +68%
Accounts Payable, Current 413K USD -86.1%
Employee-related Liabilities, Current 369K USD -67.5%
Accrued Liabilities, Current 2.88M USD +54.8%
Liabilities, Current 3.63M USD -79.6%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 35.5M USD +37.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -491M USD -4.82%
Stockholders' Equity Attributable to Parent -2.55M USD +58.5%
Liabilities and Equity 33M USD +68%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.06M USD +76.6%
Net Cash Provided by (Used in) Financing Activities -8.39M USD -216%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 35.7M shares +117%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.5M USD -970%
Deferred Tax Assets, Valuation Allowance 44.6M USD +6.92%
Operating Lease, Liability 20K USD -95.7%
Depreciation 7K USD 0%
Payments to Acquire Property, Plant, and Equipment 2K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -22.6M USD +36.4%
Lessee, Operating Lease, Liability, to be Paid 20K USD -96%
Property, Plant and Equipment, Gross 320K USD -12.6%
Operating Lease, Liability, Current 20K USD -94.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 20K USD -95%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure -15.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD -83.1%
Deferred Tax Assets, Operating Loss Carryforwards 44.5M USD +7.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 1.91M USD -5.5%
Operating Lease, Payments 333K USD -5.4%
Additional Paid in Capital 488M USD
Amortization of Intangible Assets 342K USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%